Exercise Programs for High-Risk Metabolic Syndrome
Trial Summary
What is the purpose of this trial?
Among African-American women, in whom metabolic syndrome (MetS) is very prevalent and breast cancer mortality rates are high, it is hypothesized that intervening on MetS to improve the MetS profile may prove to be a means to reduce breast cancer risk. Specific recommendations for breast cancer prevention are now focused on maintaining a healthy weight via increased physical activity levels, and losing weight if overweight or obese. This pilot project compares two exercise interventions: a supervised facility-based and a home-based exercise intervention to a control group in African-American women with metabolic syndrome who are at high risk for breast cancer. This study is a 6-month three-arm RCT to assess the impact of the exercise interventions on biomarkers related to obesity, insulin-related pathways, inflammation, hormones, and micro-RNAs. The specific aim of the proposed study is to compare the impact of a supervised facility-based and a home-based exercise intervention on obesity, metabolic syndrome and known breast cancer biomarkers in postmenopausal African-American women with metabolic syndrome who are at increased risk of breast cancer.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you use anti-diabetic medication, including insulin.
What data supports the effectiveness of the treatment for high-risk metabolic syndrome?
Is exercise safe for people with metabolic syndrome?
How is the exercise program treatment for metabolic syndrome different from other treatments?
This treatment is unique because it offers both facility-based and home-based exercise options, potentially using telemonitoring to make it more accessible and personalized. Unlike standard treatments that may focus on medication, this approach emphasizes lifestyle changes through regular exercise, which can be more sustainable and cost-effective in managing metabolic syndrome.6791011
Eligibility Criteria
This trial is for African-American postmenopausal women aged 45-65 with metabolic syndrome, living near the Navy Yard stop on the green line. They must read and speak English, have a cell phone, be able to consent, get medical clearance, and not be pregnant or planning pregnancy. Excluded are those in other trials, on weight loss programs or with physical limitations preventing exercise.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline assessments prior to randomization
Treatment
Participants engage in either a supervised facility-based or home-based exercise intervention for 6 months
Follow-up
Participants are monitored for changes in biomarkers and health-related quality of life
Treatment Details
Interventions
- Facility-based Exercise
- Home-based Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
Georgetown University
Lead Sponsor